Topics
January/February 2016 | Special Focus: Inside The Treatment Pipeline
Reversing Retinal Ischemia
Using encapsulated cell technology, a novel device may some day be used to treat inadequate oxygenation associated with common diseases.
Logan Christensen, MD, and Jeffrey L. Olson, MD
October 9, 2026
Perceive Bio Completes Phase 2a Enrollment in VOY-101 Gene Therapy Study for Geographic Atrophy
Haag-Streit Launches Eyesi Surgical 3.0 Virtual Reality Training Platform at AAO
October 7, 2026
Atsena Reports Preliminary ATSN-201 Results in X-linked Retinoschisis
Study Links GLP-1 Use to Earlier Fellow-Eye NAION Involvement
October 2026 Insert
Editorially Independent Content, Supported With Advertising From Asetllas
Editorially independent supported by Abbvie and Regenxbio
Free Print Subscription
Email Newsletter
Conference Calendar
